Anesthesia Induction Schemes of Electroconvulsive Convulsions in Patients With Depression Based on EEG Monitoring
Depression, Electroconvulsive Therapy, Electroencephalography
About this trial
This is an interventional supportive care trial for Depression focused on measuring Depression,Electroconvulsive Therapy,Electroencephalography
Eligibility Criteria
Inclusion Criteria: In-patients who meet the diagnostic criteria of moderate and severe depression in the 11th edition of the International Classification of Diseases (ICD-11) Age 18-60 years old, gender unlimited Primary school or above education level Indications for MECT treatment Normal hearing and vision (including color discrimination) The patient voluntarily participated in the study and signed the informed consent form, and the guardian also signed the informed consent form. Exclusion Criteria: History of physical disease, brain organic disease and abuse of alcohol and psychoactive substances Patients with bipolar disorder Primary insomnia Combined with other mental diseases Combined with obesity, diabetes and other metabolic diseases Combined with hypertension, cardiovascular disease or cerebrovascular disease Combined with Alzheimer's disease Pregnant and lactating women.
Sites / Locations
- The First Affiliated Hospital of Chongqing Medical UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
Group H:IoC1 60-70
Group M: IoC1 50-60
Group L:IoC1 40-50
This study used an EEG bispectral index monitor (Apolo 9000A) to monitor consciousness index 1 (IoC1) and consciousness index 2 (IoC2) before electric shock, and then induced anesthesia with propofol 1.5mg/kg and succinylcholine 1mg/kg, following by mask pressurized oxygen supply,dental pads protect the tongue and monitoring the concentration of end-expiratory carbon dioxide. Electrical stimulation is performed when the consciousness index 1 is between 60 and 70. The electrode is located on the bilateral temporal side;Electric shock equipment:ThymatronSystem Ⅳ Electroconvulsive System,manufacturer:SOMATICS, USA;Propofol manufacturer: AstraZeneca of the UK, concentration: 10mg/ml. Succinylcholine manufacturer: Shanghai Xudong Haipu Pharmaceutical Co., Ltd.China, concentration: 2ml: 0.1g.
This study used an EEG bispectral index monitor (Apolo 9000A) to monitor consciousness index 1 (IoC1) and consciousness index 2 (IoC2) before electric shock, and then induced anesthesia with propofol 1.5mg/kg and succinylcholine 1mg/kg, following by mask pressurized oxygen supply,dental pads protect the tongue and monitoring the concentration of end-expiratory carbon dioxide. Electrical stimulation is performed when the consciousness index 1 is between 50 and 60. The electrode is located on the bilateral temporal side;Electric shock equipment:ThymatronSystem Ⅳ Electroconvulsive System,manufacturer:SOMATICS, USA;Propofol manufacturer: AstraZeneca of the UK, concentration: 10mg/ml. Succinylcholine manufacturer: Shanghai Xudong Haipu Pharmaceutical Co., Ltd.China, concentration: 2ml: 0.1g.
This study used an EEG bispectral index monitor (Apolo 9000A) to monitor consciousness index 1 (IoC1) and consciousness index 2 (IoC2) before electric shock, and then induced anesthesia with propofol 1.5mg/kg and succinylcholine 1mg/kg, following by mask pressurized oxygen supply,dental pads protect the tongue and monitoring the concentration of end-expiratory carbon dioxide. Electrical stimulation is performed when the consciousness index 1 is between 40 and 50. The electrode is located on the bilateral temporal side;Electric shock equipment:ThymatronSystem Ⅳ Electroconvulsive System,manufacturer:SOMATICS, USA;Propofol manufacturer: AstraZeneca of the UK, concentration: 10mg/ml. Succinylcholine manufacturer: Shanghai Xudong Haipu Pharmaceutical Co., Ltd.China, concentration: 2ml: 0.1g.